Log in
Enquire now
‌

US Patent 10059774 Antibody therapeutics that bind CD38

Patent 10059774 was granted and assigned to Sorrento Therapeutics on August, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Sorrento Therapeutics
Sorrento Therapeutics
Date Filed
April 8, 2016
Date of Patent
August 28, 2018
Patent Applicant
Sorrento Therapeutics
Sorrento Therapeutics
Patent Application Number
15094384
Patent Citations Received
‌
US Patent 11999792 Antibody therapeutics that bind CD38
0
‌
US Patent 11760806 CD-38 directed chimeric antigen receptor constructs
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10059774
Patent Primary Examiner
‌
Hong Sang

Find more entities like US Patent 10059774 Antibody therapeutics that bind CD38

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.